Keywords: pharmaceutical industry, globalisation, biotechnology, innovation and technology platforms
The global pharmaceutical industry: changing competitive landscape
The paper analyses the changing landscape of the global pharmaceutical industry. The study analyses the forces driving the change and the enabling factors that facilitate the response of various firms in the pharmaceutical industry, leading to consolidation and restructuring of the industry. A number of new technology platforms are emerging that are facilitating this change process. In the post-GATT era, smaller firms can survive only if they are innovative or are networked. Firms will no longer be able to survive the competition without integrating into the global market. The health care delivery system would also need to be revamped in order to deal with the magnitude of the problem of quality healthcare in third world countries.